Abstract | INTRODUCTION: PATIENTS AND METHODS: Sera from eight consecutive biopsy-proven systemic WG patients (four men and four women; age at diagnosis 58.4 +/- 13.8 years) were obtained longitudinally with a follow-up period of 55.2 +/- 30 months. Sera obtained from 50 healthy subjects were used as controls. RESULTS AND DISCUSSION: Serum levels of IL-18, IL-18BP, and free IL-18 obtained during an active phase of the disease (Birmingham Vasculitis Activity Score, BVAS > 10) were more than twofold higher than levels in the same patients during inactive disease stages (BVAS < 5; P < 0.002; P < 0.006, and P < 0.03 for IL-18, IL-18BP, and free IL-18, respectively). During inactive stages, the levels of these markers were comparable to those of healthy controls. The elevated levels of IL-18 and IL-18BP in sera during active stages of disease suggest a possible role in the pathogenesis and course of the WG. CONCLUSION: Despite the elevated IL-18BP levels during active disease, free IL-18 remained higher than in the inactive disease stages, suggesting a potential benefit of administration of exogenous IL-18BP as a novel therapeutic approach for active WG.
|
Authors | D Novick, D Elbirt, C A Dinarello, M Rubinstein, Z M Sthoeger |
Journal | Journal of clinical immunology
(J Clin Immunol)
Vol. 29
Issue 1
Pg. 38-45
(Jan 2009)
ISSN: 1573-2592 [Electronic] Netherlands |
PMID | 18594952
(Publication Type: Journal Article)
|
Chemical References |
- Biomarkers
- Intercellular Signaling Peptides and Proteins
- Interleukin-18
- interleukin-18 binding protein
|
Topics |
- Aged
- Biomarkers
(blood)
- Female
- Follow-Up Studies
- Granulomatosis with Polyangiitis
(blood, diagnosis)
- Humans
- Intercellular Signaling Peptides and Proteins
(blood)
- Interleukin-18
(blood)
- Longitudinal Studies
- Male
- Middle Aged
|